Depressive Symptom Profiles and Survival in Older Patients with Cancer: Latent Class Analysis of the ELCAPA Cohort Study.

BACKGROUND The expression of depressive symptoms in older people with cancer is heterogeneous because of specific features of age or cancer comorbidity. We aimed to identify depressive symptom profiles in this population and describe the associated features including survival. MATERIALS AND METHODS Patients ≥70 years who were referred to geriatric oncology clinics were prospectively included in the ELCAPA study. In this subanalysis, depressive symptoms were used as indicators in a latent class analysis. Multinomial multivariable logistic regression and Cox models examined the association of each class with baseline characteristics and mortality. RESULTS For the 847 complete-case patients included (median age, 79 years; interquartile range, 76-84; women, 47.9%), we identified five depressive symptom classes: "no depression/somatic only" (38.8%), "no depression/pauci-symptomatic" (26.4%), "severe depression" (20%), "mild depression" (11.8%), and "demoralization" (3%). Compared with the no depression/pauci-symptomatic class, the no depression/somatic only and severe depression classes were characterized by more frequent comorbidities with poorer functional status and higher levels of inflammation. "Severe" and "mild" depression classes also featured poorer nutritional status, more medications, and more frequent falls. Severe depression was associated with poor social support, inpatient status, and increased risk of mortality at 1 year (adjusted hazard ratio, 1.62, 95% confidence interval, 1.06-2.48) and 3 years (adjusted hazard ratio, 1.49; 95% confidence interval, 1.06-2.10). CONCLUSION A data-driven approach based on depressive symptoms identified five different depressive symptom profiles, including demoralization, in older patients with cancer. Severe depression was independently and substantially associated with poor survival. IMPLICATIONS FOR PRACTICE Older patients with cancer present with distinct profiles of depressive symptomatology, including different severity levels of depression and the demoralization syndrome. Clinicians should use a systematic assessment of depressive symptoms to adequately highlight these distinct profiles. Geriatric and oncological features are differently associated with these profiles. For instance, severe depression was associated with more frequent comorbidities with poorer functional, poor nutritional status, polypharmacy, frequent falls, inpatient status and poor social support. Also, severe depression was independently and substantially associated with poor survival so that the identification and management of depression should be considered a high priority in this population.

[1]  R. Philipp,et al.  Existential distress and meaning-focused interventions in cancer survivorship , 2017, Current opinion in supportive and palliative care.

[2]  A. Mehnert,et al.  The association of demoralization with mental disorders and suicidal ideation in patients with cancer , 2017, Cancer.

[3]  A. Mitchell,et al.  Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review , 2017, Acta oncologica.

[4]  V. Brouste,et al.  Predictive factors of depressive symptoms of elderly patients with cancer receiving first‐line chemotherapy , 2017, Psycho-oncology.

[5]  C. Nelson,et al.  Towards a new conceptualization of depression in older adult cancer patients: a review of the literature , 2016, Aging & mental health.

[6]  G. Fava,et al.  Current Psychosomatic Practice , 2016, Psychotherapy and Psychosomatics.

[7]  C. Tournigand,et al.  Geriatric assessment findings independently associated with clinical depression in 1092 older patients with cancer: the ELCAPA Cohort Study , 2016, Psycho-oncology.

[8]  Hsiu-Hung Wang,et al.  A Systematic Review and Meta-Analysis of Demoralization and Depression in Patients With Cancer. , 2015, Psychosomatics.

[9]  N. Avis,et al.  Trajectories of Depressive Symptoms Following Breast Cancer Diagnosis , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[10]  R. Sanderman,et al.  Subtypes of depression in cancer patients: an empirically driven approach , 2015, Supportive Care in Cancer.

[11]  C. Tournigand,et al.  Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With Cancer. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[12]  F. Buntinx,et al.  A cohort study on the evolution of psychosocial problems in older patients with breast or colorectal cancer: comparison with younger cancer patients and older primary care patients without cancer , 2015, BMC Geriatrics.

[13]  N. Hoertel,et al.  Comorbidity of late-life depression in the United States: a population-based study. , 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[14]  B. Muthén,et al.  Auxiliary Variables in Mixture Modeling: Three-Step Approaches Using Mplus , 2014 .

[15]  Pim Cuijpers,et al.  Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. , 2014, The American journal of psychiatry.

[16]  L. Remontet,et al.  Cancer incidence and mortality in France over the 1980-2012 period: solid tumors. , 2014, Revue d'epidemiologie et de sante publique.

[17]  R. Kessler,et al.  Data-driven subtypes of major depressive disorder: a systematic review , 2012, BMC Medicine.

[18]  Y. Kuo,et al.  The effect of depression on stage at diagnosis, treatment, and survival in pancreatic adenocarcinoma. , 2012, Surgery.

[19]  R. Dantzer,et al.  Translational approaches to treatment-induced symptoms in cancer patients , 2012, Nature Reviews Clinical Oncology.

[20]  A. Ravaud,et al.  Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  E. Giltay,et al.  Phenomenology of depression in older compared with younger adults: meta-analysis. , 2012, The British journal of psychiatry : the journal of mental science.

[22]  S. Culine,et al.  Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  N. Meader,et al.  Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. , 2011, The Lancet. Oncology.

[24]  D. Blazer,et al.  Heterogeneity in symptom profiles among older adults diagnosed with major depression , 2011, International Psychogeriatrics.

[25]  M. Pinquart,et al.  Depression and cancer mortality: a meta-analysis , 2010, Psychological Medicine.

[26]  J. Holland,et al.  Are gold standard depression measures appropriate for use in geriatric cancer patients? A systematic evaluation of self-report depression instruments used with geriatric, cancer, and geriatric cancer samples. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  W. Linden,et al.  Depression as a predictor of disease progression and mortality in cancer patients , 2009, Cancer.

[28]  T. Nakano,et al.  Symptom indicator of severity of depression in cancer patients: a comparison of the DSM-IV criteria with alternative diagnostic criteria. , 2009, General hospital psychiatry.

[29]  J. Suls,et al.  Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis , 2009, Psychosomatic medicine.

[30]  P. Cuijpers,et al.  An epidemiological approach to depression prevention in old age. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[31]  B. Muthén,et al.  Deciding on the Number of Classes in Latent Class Analysis and Growth Mixture Modeling: A Monte Carlo Simulation Study , 2007 .

[32]  R. Yancik,et al.  Population aging and cancer: a cross-national concern. , 2005, Cancer journal.

[33]  L. Cox,et al.  Social and Behavioral Correlates of Cigarette Smoking among Mid-Atlantic Latino Primary Care Patients , 2005, Cancer Epidemiology Biomarkers & Prevention.

[34]  D. Kissane The contribution of demoralization to end of life decisionmaking. , 2004, The Hastings Center report.

[35]  P. Donnan,et al.  Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas , 2004, British Journal of Cancer.

[36]  J. M. Figueiredo Depression and demoralization: phenomenologic differences and research perspectives. , 1993 .

[37]  L. A. Goodman Exploratory latent structure analysis using both identifiable and unidentifiable models , 1974 .

[38]  C. Nelson,et al.  Untangling the complexities of depression diagnosis in older cancer patients. , 2009, The oncologist.

[39]  J. Vermunt Latent Class Models , 2004 .

[40]  D. Kuh,et al.  Characterizing Longitudinal Patterns of Physical Activity in Mid-Adulthood Using Latent Class Analysis: Results From a Prospective Cohort Study , 2011, American journal of epidemiology.